News
Hims & Hers stands out for personalized, compounded medications and consistent margin expansion but faces rising risks tied ...
3don MSN
Hims & Hers Health (HIMS -3.91%) is a telehealth company that offers personalized solutions for its customers. And demand has ...
Hims & Hers (NYSE: HIMS) and UnitedHealth (NYSE: UNH) suffered huge stock price decreases that attracted investors looking to ...
San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...
Hims & Hers' high valuation is no longer justified amid mounting execution and revenue risks. Click here to read why I ...
The fortune of the San Francisco-based telehealth company’s cofounder and chief executive, Andrew Dudum, crumbled by more ...
Novo Nordisk ended a short-lived agreement to sell its Wegovy weight-loss drug through Hims & Hers Health on Monday, sending ...
Novo Nordisk said Monday it will end its collaboration with Hims & Hers that offered the weight loss medication Wegovy for ...
The loss of its ability to sell Wegovy is a significant hit to Hims & Hers' business. The massive drop today in its stock ...
The Danish pharmaceutical said it was ending the partnership because Hims is selling and promoting a cheaper copycat of its ...
The companies engaged in an increasingly heated war of words on Monday following the drugmaker's decision to end a ...
2d
MarketBeat on MSNWhy Hims & Hers Is a Buy Below $35 After Its 16% PullbackThere is always a challenging moment in every investor’s favorite stock and portfolio, especially when said businesses are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results